Prime
Treatments
Testing and Advancements Index
The Prime Treatments, Testing and Advancements Index is designed to track both event-driven news and long-term trends of companies engaged in developing treatments and vaccines, or diagnostic technology, in the fight against infectious diseases.
FACT SHEET
Prime Treatments, Testing and Advancements Primer
PDF
Infectious Diseases: Prime Treatments, Testing and Advancements Overview
PDF
Prime Treatments, Testing and Advancements Index Methodology Guide
PDF
Prime Treatments, Testing and Advancements Factsheet
PDF
Prime Treatments, Testing and Advancements Index
VIDEO
INDEX KEY FACTS
Base Date: December 12, 2019
Total number of holdings:
52
Launch date: June 08, 2020
Reconstitution: Quarterly (March, June, September and December)
Index calculation agent: Solactive AG
Weighting scheme: Modified Market Capitalization
INDEX SYMBOLS
| Version | Bloomberg | Reuters | ISIN |
|---|---|---|---|
| Prime Treatments, Testing and Advancements Index GTR | PGERM | .PGERMG | DE000SL0A030 |
| Prime Treatments, Testing and Advancements Index NTR | N/A | .PGERMN | DE000SL0A022 |
| Prime Treatments, Testing and Advancements Index PR | N/A | .PGERMP | DE000SL0A014 |
INDEX COMPOSITION
| Component Name | Ticker | Weight |
|---|---|---|
| ALNYLAM PHARMACEUTICALS INC | ALNY | 9.37% |
| LABCORP HOLDINGS INC | LH | 6.33% |
| QUEST DIAGNOSTICS INC | DGX | 6.08% |
| BIONTECH SE | BNTX | 5.03% |
| MODERNA INC | MRNA | 4.70% |
| VAXCYTE INC | PCVX | 4.60% |
| BIO-RAD LABORATORIES INC | BIO | 4.39% |
| ZAI LAB LTD | ZLAB | 3.94% |
| IMMUNOCORE HOLDINGS PLC | IMCR | 3.73% |
| IMMUNITYBIO INC | IBRX | 3.66% |
| QUIDELORTHO CORPORATION | QDEL | 3.63% |
| BIOCRYST PHARMACEUTICALS INC | BCRX | 3.60% |
| NOVAVAX INC | NVAX | 3.47% |
| DYNAVAX TECHNOLOGIES CORP | DVAX | 3.37% |
| VIR BIOTECHNOLOGY INC | VIR | 3.23% |
| OPKO HEALTH INC | OPK | 2.29% |
| CUREVAC BV | CVAC | 1.85% |
| SIGA TECHNOLOGIES INC | SIGA | 1.66% |
| ARBUTUS BIOPHARMA CORP | ABUS | 1.63% |
| EMERGENT BIOSOLUTIONS INC | EBS | 1.62% |
| FULGENT GENETICS INC | FLGT | 1.57% |
| ADAPTIVE BIOTECHNOLOGIES CORP | ADPT | 1.47% |
| ARCTURUS THERAPEUTICS HOLDINGS INC | ARCT | 1.44% |
| GILEAD SCIENCES INC | GILD | 1.00% |
| OCUGEN INC | OCGN | 0.94% |
| ABBVIE INC | ABBV | 0.91% |
| JOHNSON & JOHNSON | JNJ | 0.91% |
| REGENERON PHARMACEUTICALS | REGN | 0.89% |
| PFIZER INC | PFE | 0.88% |
| SANOFI-ADR | SNY | 0.88% |
| TAKEDA PHARM-ADR | TAK | 0.84% |
| ABBOTT LABORATORIES | ABT | 0.83% |
| ASTRAZENECA PLC-SPONS ADR | AZN | 0.80% |
| ELI LILLY & CO | LLY | 0.79% |
| GSK PLC-SPON ADR | GSK | 0.79% |
| MERCK & CO. INC. | MRK | 0.79% |
| ATEA PHARMACEUTICALS INC | AVIR | 0.73% |
| ENANTA PHARMACEUTICALS INC | ENTA | 0.73% |
| ORASURE TECHNOLOGIES INC | OSUR | 0.71% |
| INOVIO PHARMACEUTICALS INC | INO | 0.65% |
| CORMEDIX INC | CRMD | 0.55% |
| XBIOTECH INC | XBIT | 0.49% |
| RENOVARO BIOSCIENCES INC | RENB | 0.43% |
| INVIVYD INC | IVVD | 0.35% |
| VAXART INC | VXRT | 0.27% |
| HILLEVAX INC | HLVX | 0.21% |
| INFLARX NV | IFRX | 0.20% |
| CHIMERIX INC | CMRX | 0.18% |
| AN2 THERAPEUTICS INC | ANTX | 0.18% |
| GRITSTONE BIO INC | GRTS | 0.16% |
| CEL-SCI CORP | CVM | 0.16% |
| CUE BIOPHARMA INC | CUE | 0.07% |